Amylomaltase (AM; EC 2.4.1.25) belongs to the 4--glucanotransferase group of the -amylase family. The enzyme can produce cycloamylose or large-ring cyclodextrin through intramolecular transglycosylation or cyclization reactions of -1,4-glucan. Amylomaltase from the mesophilic bacterium Corynebacterium glutamicum (CgAM) contains extra residues at the N-terminus for which the three-dimensional structure is not yet known. In this study, CgAM was overexpressed and purified to homogeneity using DEAE FF and Phenyl FF columns. The purified CgAM was crystallized by the vapour-diffusion method. Preliminary X-ray data showed that the CgAM crystal diffracted to 1.7 Å resolution and belonged to space group P2 1 2 1 2 1 , with unit-cell parameters a = 73.28, b = 82.61, c = 118.64 Å . To obtain the initial phases, crystals of selenomethionyl-substituted amylomaltase were produced, and multiplewavelength anomalous dispersion phasing and structure refinement are now in progress.
Introduction
Amylomaltase (EC 2.4.1.25) is a member of the 4--glucanotransferase (4GTase) group of the -amylase family. Amylomaltase catalyses the hydrolysis and transfer of -1,4-glucan units to another linear oligosaccharide: the so-called intermolecular transglycosylation or disproportionation reaction. The enzyme also catalyses a unique intramolecular transglycosylation reaction or cyclization reaction within a single -d-glucan molecule, producing cycloamylose (CA) or large-ring cyclodextrin (LR-CD), a cyclic -1,4-glucan with a degree of polymerization (DP) of 16 or higher (Takaha & Smith, 1999) . LR-CDs can form inclusion complexes with various guest molecules and potentially improve the properties of guest molecules such as their solubility, stability and reactivity (Zheng et al., 2002; Tomono et al., 2002) .
Amylomaltases have been found in microorganisms as well as in plants, where they are known as disproportionating enzymes (D-enzymes; Takaha et al., 1996; Kakefuda & Duke, 1989; Lin & Preiss, 1988) . In microorganisms, amylomaltase was first identified in Escherichia coli as a maltose-inducible enzyme (Monod & Torriani, 1950) . Later, amylomaltases from many archaea and bacterial strains, including from Corynebacterium glutamicum, were characterized (Kaper et al., 2005 Terada et al., 1999; Godá ny et al., 2008; Srisimarat et al., 2011) Roujeinikova et al., 2002) and Solanum tuberosum (PDB entry 1x1n; Imamura et al., 2005) have been determined. However, the amylomaltase from C. glutamicum (CgAM) showed low amino-acid sequence similarity (28-32%) to these amylomaltases. CgAM showed a different LR-CD production profile from that of the well characterized T. aquaticus enzyme (Terada et al., 1999; Srisimarat et al., 2011) . CgAM gave CA with a DP of 19 and higher, while T. aquaticus amylomaltase produced CD22 as the smallest product. In addition, the LR-CD production profile of CgAM depended on the incubation time and the enzyme concentration. The X-ray crystal structure of T. aquaticus amylomaltase illustrated the well conserved catalytic site along with another substrate-binding site, the so-called 'second binding site'. This second binding site was proposed to play a role in LR-CD formation through the hydrophobic interaction of Tyr54 and Tyr101 with substrate. The mutation of these residues altered the hydrolysis activity of T. aquaticus amylomaltase, resulting in changes in the cyclization activity of the enzyme (Fujii et al., , 2007 . In addition, a recent study of the Y172A mutant, CgAM with an alanine substitution at Tyr172, which corresponds to Tyr54 in T. aquaticus amylomaltase, also suggested that Tyr172 of CgAM plays an important role in determination of the LR-CD production profile (Srisimarat et al., 2012) .
To date, no crystal structure of CgAM has been reported. Multiple amino-acid sequence alignment of CgAM and other thermostable amylomaltases showed that CgAM contains an extra N-terminal region of approximately 240 amino acids that does not share sequence similarity with other enzymes (Srisimarat et al., 2011) . In order to identify the function of this region and understand the basis of the cyclization mechanism of CgAM, the crystallization and preliminary X-ray analysis of full-length CgAM (residues 1-706) are reported in this study.
Materials and methods

Expression and purification
The ORF of CgAM (GenBank BAB99690.1) has 2121 bp and was deduced to encode 706 amino-acid residues (Fig. 1) . Full-length CgAM was overexpressed and purified as described previously (Srisimarat et al., 2012) . In brief, E. coli BL21 (DE3) cells harbouring the pET-CgAM plasmid were cultured in Luria-Bertani medium containing 100 mg ml À1 ampicillin at 310 K and expression of CgAM was induced by the addition of -d-1-thiogalactopyranoside (IPTG) to a final concentration of 0.4 mM. After 2 h, the cultured cells were harvested and disrupted by sonication (Bandelin, Germany). Cell debris was removed by centrifugation and the supernatant was applied onto DEAE FF and Phenyl FF (GE Healthcare, UK). The protein fractions containing amylomaltase activity were then collected. The purity of the protein was determined by 7.5% SDS-PAGE.
Crystallization
The purified protein was dialysed in 10 mM phosphate buffer pH 6.0 and concentrated to 5 mg ml À1 . The concentration of protein was measured using the BCA Protein Assay Kit (Pierce, USA). Crystal-lization experiments were carried out at 291 K using the vapourdiffusion method. Crystallization conditions were screened using the Index screen (Hampton Research, USA) in sitting droplets consisting of 0.5 ml protein solution and 0.5 ml precipitant solution in a 96-well plate. After a week, small crystals appeared in a droplet containing precipitant solution consisting of 0.1 M bis-tris pH 5.5, 2.0 M ammonium sulfate. Diffraction-quality crystals were produced in a VDX plate (Hampton Research, USA) using the hanging-drop vapour-diffusion method.
Data collection and processing
Prior to data collection, the crystal was immersed in reservoir solution supplemented with 30%(v/v) xylitol for a few seconds and was then flash-cooled in liquid nitrogen. X-ray diffraction data were collected from the crystal using an ADSC Quantum 315r CCD area detector on BL13B1 at the National Synchrotron Radiation Research Center (NSRRC), Taiwan. Data were processed using the HKL-2000 software package (Otwinowski & Minor, 1997) .
Results and discussion
Recombinant CgAM was overexpressed and purified using DEAE and Phenyl FF column chromatography. Purified CgAM shows a single band on SDS-PAGE with an apparent molecular mass of 81 kDa. Crystals suitable for data collection were produced as described in x2. The crystal grew to maximum dimensions of 0.2 Â 0.4 Â 0.1 mm (Fig. 2) and diffracted to 1.7 Å resolution at a synchrotron source. The crystal belonged to space group P2 1 2 1 2 1 , with unit-cell parameters a = 73. The deduced amino-acid sequence of amylomaltase from C. glutamicum ATCC 13032.
Figure 2
Crystals of CgAM with approximate dimensions of 0.2 Â 0.4 Â 0.1 mm. has a resolution range of 50-1.7 Å with 97.3% completeness and an R merge of 5.5%. The Matthews coefficient was calculated to be about 2.26 Å 3 Da À1 , corresponding to 46% solvent content (Matthews, 1968; Kantardjieff & Rupp, 2003) . Diffraction statistics are summarized in Table 1 .
Attempts were made to solve the crystal structure of CgAM using the molecular-replacement method. The structures of amylomaltases from PDB entries 1esw (28% sequence similarity; and 1tz7 (32% sequence similarity; T. R. M. Barends, H. Korf, T. Kaper, M. J. E. C. van der Maarel, L. Dijkhuizen & B. W. Dijkstra, unpublished work) were used as search models in MOLREP (Winn et al., 2011) . However, this method was not successful. This is probably because of conformational differences or low amino-acid sequence similarity. Since CgAM has a high methionine frequency (15 methionine residues in 706 residues), it should be possible to obtain experimental phases by the multiwavelength anomalous dispersion (MAD) method using selenomethionine-incorporated crystals. As a result, selenomethionineincorporated CgAM crystals were grown and used for MAD data collection. At present, phase determination and structure refinement of CgAM are in progress. 36.0 (6.2) R merge ‡ (%) 5.5 (31.2) Average multiplicity 11.3 (11.5) † According to Kantardjieff & Rupp (2003) . ‡ R merge = P hkl P i jI i ðhklÞ À hIðhklÞij= P hkl P i I i ðhklÞ, where I i (hkl) is the observed intensity and hI(hkl)i is the average intensity from multiple measurements (Diederichs & Karplus, 1997) .
